We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
+16.21%
1 Year Est. Return
+89.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$101M
AUM Growth
Cap. Flow
+$100M
Cap. Flow %
99.43%
Top 10 Hldgs %
36.7%
Holding
57
New
57
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 24.98%
2 Consumer Discretionary 21.59%
3 Industrials 11.72%
4 Communication Services 9.56%
5 Real Estate 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOD icon
26
Kodiak Sciences
KOD
$2.84B
$1.66M 1.65%
+166,843
New +$959K
IVAC
27
DELISTED
Intevac Inc
IVAC
$1.56M 1.55%
+459,450
New +$1.45M
ALOT icon
28
AstroNova
ALOT
$227M
$1.54M 1.52%
+127,920
New +$1.8M
ALTO icon
29
Alto Ingredients
ALTO
$340M
$1.46M 1.45%
+939,097
New +$1.47M
STHO icon
30
Star Holdings Shares of Beneficial Interest
STHO
$116M
$1.42M 1.41%
+145,846
New +$1.7M
AXR icon
31
AMREP Corp
AXR
$119M
$1.41M 1.4%
+44,925
New +$1.45M
WHWK
32
Whitehawk Therapeutics
WHWK
$235M
$1.4M 1.39%
+442,942
New +$1M
IPI icon
33
Intrepid Potash
IPI
$469M
$1.27M 1.26%
+57,904
New +$1.46M
MGX icon
34
Metagenomi Therapeutics
MGX
$46.3M
$1.27M 1.26%
+351,213
New +$847K
USAP
35
DELISTED
Universal Stainless & Alloy
USAP
$1.27M 1.26%
+28,792
New +$1.25M
UEIC icon
36
Universal Electronics
UEIC
$60.1M
$1.22M 1.2%
+110,496
New +$1.1M
AVIR icon
37
Atea Pharmaceuticals
AVIR
$420M
$1.1M 1.09%
+328,581
New +$1.09M
NUVB icon
38
Nuvation Bio
NUVB
$2.32B
$1.04M 1.03%
+391,745
New +$1.01M
ACTG icon
39
Acacia Research
ACTG
$470M
$1.03M 1.02%
+238,011
New +$1.08M
NKTR icon
40
Nektar Therapeutics
NKTR
$2.58B
$1.03M 1.02%
+73,834
New +$1.3M
FTEK icon
41
Fuel Tech
FTEK
$43.7M
$1.03M 1.02%
+977,674
New +$1.01M
ACRS icon
42
Aclaris Therapeutics
ACRS
$825M
$1M 0.99%
+404,452
New +$1.01M
GIFI
43
DELISTED
Gulf Island Fabrication
GIFI
$1M 0.99%
+146,980
New +$937K
ASMB icon
44
Assembly Biosciences
ASMB
$529M
$994K 0.98%
+62,970
New +$1.01M
SEER icon
45
Seer Inc
SEER
$120M
$991K 0.98%
+428,904
New +$940K
ITOS
46
DELISTED
iTeos Therapeutics
ITOS
$836K 0.83%
+108,853
New +$935K
KZR
47
DELISTED
Kezar Life Sciences
KZR
$833K 0.83%
+123,994
New +$924K
IMA
48
ImageneBio Inc
IMA
$64.6M
$833K 0.83%
+42,322
New +$856K
FDMT icon
49
4D Molecular Therapeutics
FDMT
$562M
$806K 0.8%
+144,743
New +$1.14M
ANTX icon
50
AN2 Therapeutics
ANTX
$214M
$799K 0.79%
+578,825
New +$702K

Similar funds

Peapod Lane Capital's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Peapod Lane Capital, which disclosed 57 positions worth $101M. Its ten largest holdings account for 37% of the portfolio.

Its largest position is Hurco Companies Inc: 244,032 shares worth $4.71M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Consumer Discretionary and Industrials.

  • Peapod Lane Capital's largest Q4 2024 buy was Hurco Companies Inc: 244,032 shares worth $4.71M.
  • Peapod Lane Capital's ten largest holdings make up 37% of its $101M portfolio in Q4 2024.
  • Peapod Lane Capital disclosed 57 positions in Q4 2024, its first 13F filing on record.

Based on Peapod Lane Capital's 13F filing for Q4 2024, filed 29 Jan 2025.